[go: up one dir, main page]

HUP0203214A3 - Process for preparing intermediates applicable for synthesis of hiv protease inhibitor - Google Patents

Process for preparing intermediates applicable for synthesis of hiv protease inhibitor

Info

Publication number
HUP0203214A3
HUP0203214A3 HU0203214A HUP0203214A HUP0203214A3 HU P0203214 A3 HUP0203214 A3 HU P0203214A3 HU 0203214 A HU0203214 A HU 0203214A HU P0203214 A HUP0203214 A HU P0203214A HU P0203214 A3 HUP0203214 A3 HU P0203214A3
Authority
HU
Hungary
Prior art keywords
synthesis
applicable
protease inhibitor
hiv protease
preparing intermediates
Prior art date
Application number
HU0203214A
Other languages
English (en)
Original Assignee
Agouron Pharmaceuticals Inc La
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals Inc La filed Critical Agouron Pharmaceuticals Inc La
Publication of HUP0203214A2 publication Critical patent/HUP0203214A2/hu
Publication of HUP0203214A3 publication Critical patent/HUP0203214A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
HU0203214A 1999-10-21 2000-10-19 Process for preparing intermediates applicable for synthesis of hiv protease inhibitor HUP0203214A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16069599P 1999-10-21 1999-10-21
PCT/US2000/028815 WO2001029013A1 (en) 1999-10-21 2000-10-19 Process for preparing oxazolines from tetrahydrofurans

Publications (2)

Publication Number Publication Date
HUP0203214A2 HUP0203214A2 (hu) 2003-01-28
HUP0203214A3 true HUP0203214A3 (en) 2005-01-28

Family

ID=22578030

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203214A HUP0203214A3 (en) 1999-10-21 2000-10-19 Process for preparing intermediates applicable for synthesis of hiv protease inhibitor

Country Status (20)

Country Link
US (3) US6403799B1 (hu)
EP (1) EP1224177B1 (hu)
JP (2) JP2003512361A (hu)
KR (1) KR100706938B1 (hu)
CN (3) CN1266140C (hu)
AT (1) ATE259360T1 (hu)
AU (1) AU775783B2 (hu)
BR (1) BR0015229A (hu)
CA (1) CA2387997C (hu)
CZ (1) CZ20021361A3 (hu)
DE (1) DE60008270T2 (hu)
DK (1) DK1224177T3 (hu)
ES (1) ES2215737T3 (hu)
HU (1) HUP0203214A3 (hu)
IL (1) IL149197A0 (hu)
PL (1) PL364878A1 (hu)
PT (1) PT1224177E (hu)
RU (1) RU2242468C2 (hu)
SI (1) SI1224177T1 (hu)
WO (1) WO2001029013A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2872491T3 (pl) 2012-07-11 2021-12-13 Blueprint Medicines Corporation Inhibitory receptora czynnika wzrostu fibroblastów
RU2704112C2 (ru) 2013-10-25 2019-10-24 Блюпринт Медсинс Корпорейшн Ингибиторы рецептора фактора роста фибробластов
US9695165B2 (en) 2014-01-15 2017-07-04 Blueprint Medicines Corporation Inhibitors of the fibroblast growth factor receptor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
CA2153777A1 (en) 1993-01-15 1994-07-21 Siegfried H. Reich Hiv protease inhibitors
EP0686157A1 (en) 1993-02-26 1995-12-13 Schering Corporation 2-benzyl-polycyclic guanine derivatives and process for preparing them
US5527829A (en) 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
ATE416158T1 (de) 1995-09-26 2008-12-15 Japan Tobacco Inc Verfahren zur herstellung von amidderivaten und ihren zwischenverbindungen
ES2233976T3 (es) 1995-09-26 2005-06-16 Japan Tobacco Inc. Procedimiento para producir derivados amidicos e intermedios.
US5962725A (en) * 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US5925759A (en) * 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
AU8029000A (en) 2001-04-30
AU775783B2 (en) 2004-08-12
US20020038033A1 (en) 2002-03-28
IL149197A0 (en) 2002-11-10
WO2001029013A1 (en) 2001-04-26
ES2215737T3 (es) 2004-10-16
CN1390210A (zh) 2003-01-08
EP1224177B1 (en) 2004-02-11
SI1224177T1 (en) 2004-06-30
CA2387997C (en) 2006-06-13
ATE259360T1 (de) 2004-02-15
US20030023092A1 (en) 2003-01-30
DE60008270T2 (de) 2004-07-15
DK1224177T3 (da) 2004-05-03
HUP0203214A2 (hu) 2003-01-28
DE60008270D1 (de) 2004-03-18
CN1539832A (zh) 2004-10-27
US6403799B1 (en) 2002-06-11
EP1224177A1 (en) 2002-07-24
PL364878A1 (en) 2004-12-27
BR0015229A (pt) 2002-07-23
JP2003512361A (ja) 2003-04-02
JP2008007522A (ja) 2008-01-17
CN1266140C (zh) 2006-07-26
HK1051365A1 (en) 2003-08-01
KR20020047255A (ko) 2002-06-21
HK1068880A1 (en) 2005-05-06
CZ20021361A3 (cs) 2003-03-12
RU2242468C2 (ru) 2004-12-20
CN1162408C (zh) 2004-08-18
PT1224177E (pt) 2004-06-30
KR100706938B1 (ko) 2007-04-11
US6472534B2 (en) 2002-10-29
CA2387997A1 (en) 2001-04-26
CN1539834A (zh) 2004-10-27

Similar Documents

Publication Publication Date Title
AP2003002757A0 (en) Process and intermediates for preparing anticancer compounds
HUP0300693A3 (en) A process for the preparation of epothilone analogs and intermediates
HUP0000283A3 (en) New process for the production of quetiapine
HUP0303144A3 (en) Process for the production of substituted 2-(2-pyridylmethyl)sulfinyl-1h-benzimidazoles
AU2001249417A1 (en) Chiral imidazoyl intermediates for the synthesis of 2-(4-imidazoyl)-cyclopropyl derivatives
AU2001291741A1 (en) Process for the synthesis of fluoroorganic compounds
HK1045309A1 (zh) 取代的哌啶-4-酮的制备
IL138127A0 (en) Process for the synthesis of hiv protease inhibitors
IL154803A0 (en) New process for the production of oxabispidines
EP1406855A4 (en) NOVEL PROCESS FOR THE PREPARATION OF RAC-BICALUTAMIDE AND INTERMEDIATE PRODUCTS THEREOF
EP1231215A4 (en) PROCESS FOR PRODUCING ASPARTYLDIPEPTIDE ESTER DERIVATIVES, NOVEL MATCHING INTERMEDIATES AND PROCESS FOR PRODUCING SUCH INTERMEDIATES
AU2002255473A1 (en) Process for preparing intermediates of hiv protease inhibitors
HUP0203214A3 (en) Process for preparing intermediates applicable for synthesis of hiv protease inhibitor
HUP0303832A3 (en) Process for preparation of baccatin iii derivatives
AU7918200A (en) Oxidation process for the preparation of intermediates useful in the synthesis of diarylpyridines
IL155733A0 (en) Improved process for production of gabapentin intermediate
HUP0302633A3 (en) Process for the synthesis of a peptide having a trp residue
SG108831A1 (en) Process for preventing formation of scale
AU9223601A (en) 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
HU0104563D0 (en) Process for producing of food-enzymes
HUP0104259A3 (en) A process for the synthesis of ritonavir
AU2001292236A1 (en) 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
AU2002253800A1 (en) Process for preparing intermediates of hiv protease inhibitors
AU2001243435A1 (en) Intermediates useful for the synthesis of huperzine a
SI1066276T1 (en) Process for the synthesis of hiv protease inhibitors

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees